Therapeutic potential of sunitinib in the treatment of malignant islet cell tumor / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
;
(12): 618-620, 2011.
Article
in Chinese
| WPRIM
| ID: wpr-415369
ABSTRACT
Malignant islet cell tumor, a rare type of neuroendocrine carcinoma, biologically behaves in an aggressive way and is difficulty to be treated. Sunitinib malate, a novel tyrosine kinase inhibitor, demonstrates a high efficacy in treating malignant islet cell tumor as shown by promising results in recent trials.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Endocrinology and Metabolism
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS